Greenlight biosciences crunchbase
WebFounders Justin Gover. Operating Status Active. Legal Name Greenwich Biosciences, Inc. Company Type For Profit. Phone Number 760-795-2200. Greenwich Biosciences' vision is to make a positive difference in the lives of patients through the development of a portfolio of cannabinoid prescription medicines in a wide range of therapeutic indications. WebGreenlight Biosciences Announced Date Sep 13, 2024 Funding Type Series D Funding Stage Late Stage Venture Money Raised $18M Lead Investors Fall Line Capital Fall Line Capital primarily seeks investment in broadacre farmland and agricultural technologies. Investors Number of Investors 6 Number of Partner Investors 5 Recent News News • …
Greenlight biosciences crunchbase
Did you know?
WebGreenlight Biosciences Announced Date Sep 13, 2024 Funding Type Series D Funding Stage Late Stage Venture Money Raised $18M Lead Investors Fall Line Capital Fall Line … WebAug 12, 2024 · Boston Business Journal — Boston biotech raises $109M to fuel platform for vaccines, crop protection. News • Aug 12, 2024. BioSpace — GreenLight Biosciences …
WebSearch Crunchbase. Start Free Trial . Solutions. Products. Resources. Pricing. Resources. Log In. Build Query: Press References . Save Search . Companies Contacts Investors Funding Rounds Acquisitions People Events Schools Hubs Saved Press References . Mentioned Entities . Add Press References filter . WebPrimary Organization Greenlight Biosciences Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Female LinkedIn View on LinkedIn Susan Keefe is CFO at GreenLight Biosciences.Susan Keefe attended The University of Chicago Booth School of Business. Jobs Number of Current Jobs 2
WebAug 12, 2013 · Greenlight Biosciences Announced Date Aug 12, 2013 Funding Type Series A Funding Stage Early Stage Venture Money Raised $7M Lead Investors Kodiak Venture Partners Kodiak Venture Partners pursues a disciplined investment strategy that is focused on building seed and early stage technology companies WebJul 22, 2015 · Greenlight Biosciences raised an undisclosed amount on 2015-07-22 in Series C. Unlock even more features with Crunchbase Pro
WebSusan Keefe has 2 current jobs as Chief financial officer at Greenlight Biosciences and Chief Financial Officer at Greenlight Biosciences. Additionally, Susan Keefe has had 1 …
WebAug 12, 2024 · Greenlight Biosciences. Announced Date Aug 12, 2024. Funding Type Post-IPO Equity. Money Raised $109M. how to solve degree and minutes addition trigWebGreenlight Biosciences Location Cambridge, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male LinkedIn View on LinkedIn Drew Cunningham is the Vice President of Platform Research & Development at GreenLight Biosciences, Inc. He attended Carnegie Mellon University. Jobs Number of … how to solve demand scheduleWebMay 12, 2024 · Greenlight Biosciences Announced Date May 12, 2024 Funding Type Venture - Series Unknown Money Raised $17M Investors Number of Investors 3 Number … how to solve delta and epsilon problemsWebGreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health. Medford, Massachusetts, United States 251-500 Post-IPO … Newlight Technologies is a biotechnology company producing advanced … Amyris Biotechnologies creates renewable products that focus on fuels and … Greenlight Biosciences has raised a total of $449.5M in funding over 10 rounds. … Greenlight Biosciences has 16 current employee profiles, including Co-founder … Endpoints News — GreenLight Biosciences celebrates manufacturing milestone for … Companies like Greenlight Biosciences include Inari, Amyris, and Newlight … Greenlight Biosciences uses 19 technology products and services including HTML5 … novavax business insiderWebAug 12, 2024 · Greenlight Biosciences GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health. Frequency Therapeutics Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. how to solve demand management problemsWebJan 8, 2024 · Greenlight Biosciences Announced Date Jan 8, 2024 Funding Type Venture - Series Unknown Money Raised $50M Lead Investors S2G Ventures S2G Ventures is a multi-stage venture fund focusing on investments in food and agriculture industries. how to solve data analysis problemsWebGreenlight Biosciences Post-IPO Equity $125,500,000 Feb 3, 2024 View all 10 Funding Rounds from this search When you upgrade to Crunchbase Pro, you can access all … novavax covid vaccine for kids